PBYI
Puma Biotechnology Inc
NASDAQ: PBYI · HEALTHCARE · BIOTECHNOLOGY
$7.48
-0.80% today
Updated 2026-04-29
Market cap
$382.08M
P/E ratio
12.31
P/S ratio
1.67x
EPS (TTM)
$0.61
Dividend yield
—
52W range
$3 – $8
Volume
0.4M
Puma Biotechnology Inc (PBYI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $-281096.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $27.70M | $251.00M | $272.26M | $225.11M | $253.16M | $228.03M | $235.64M | $230.47M | $228.37M |
| Revenue growth (YoY) | — | — | — | — | — | +100.0% | — | — | — | — | — | +806.1% | +8.5% | -17.3% | +12.5% | -9.9% | +3.3% | -2.2% | -0.9% |
| Cost of revenue | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $776000.00 | $1.15M | $5.60M | $34.60M | $36.81M | $39.37M | $63.70M | $55.09M | $62.68M | $64.40M | $58.16M |
| Gross profit | — | — | — | — | $-281096.00 | $0.00 | $0.00 | $0.00 | $-776000.00 | $-1.15M | $22.10M | $216.40M | $235.44M | $185.74M | $189.45M | $172.94M | $172.96M | $166.06M | $170.21M |
| Gross margin | — | — | — | — | 100.0% | — | — | — | — | — | 79.8% | 86.2% | 86.5% | 82.5% | 74.8% | 75.8% | 73.4% | 72.1% | 74.5% |
| R&D | — | — | — | — | $826372.00 | $49.60M | $45.05M | $122.90M | $208.50M | $222.80M | $207.80M | $164.90M | $132.85M | $97.65M | $71.87M | $52.24M | $50.38M | $54.94M | $62.07M |
| SG&A | — | $14083.00 | $16836.00 | $15976.00 | $9.32M | $24.80M | $9.79M | $19.40M | $31.80M | $53.80M | $106.70M | $146.19M | $140.51M | $118.49M | $116.29M | $89.98M | $88.43M | $80.68M | $71.21M |
| Operating income | $-15.09M | $-14083.00 | $-16836.00 | $-15976.00 | $-10.16M | $-74.40M | $-54.83M | $-142.30M | $-240.30M | $-276.60M | $-292.40M | $-94.70M | $-75.59M | $-30.40M | $1.29M | $23.72M | $32.64M | $30.97M | $37.30M |
| Operating margin | — | — | — | — | 3613.2% | — | — | — | — | — | -1055.6% | -37.7% | -27.8% | -13.5% | 0.5% | 10.4% | 13.9% | 13.4% | 16.3% |
| EBITDA | $-15.09M | $-14083.00 | $-16836.00 | $-15976.00 | $-10.22M | $-74.14M | $-54.41M | $-141.67M | $-239.52M | $-275.45M | $-288.42M | $-95.21M | $-52.45M | $-35.71M | $-4.69M | $21.89M | $47.52M | $48.08M | $53.34M |
| EBITDA margin | — | — | — | — | 3636.5% | — | — | — | — | — | -1041.2% | -37.9% | -19.3% | -15.9% | -1.9% | 9.6% | 20.2% | 20.9% | 23.4% |
| EBIT | $-15.09M | $-14083.00 | $-16836.00 | $-15976.00 | $-10.23M | $-74.40M | $-54.83M | $-142.30M | $-240.30M | $-276.60M | $-291.24M | $-102.59M | $-60.52M | $-45.74M | $-15.99M | $12.05M | $36.00M | $36.55M | $42.40M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $3783.00 | $98000.00 | $172000.00 | $324000.00 | $971000.00 | $958000.00 | $720000.00 | $11.00M | $15.00M | $14.05M | $12.81M | $11.59M | $13.33M | $12.45M | $6.62M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-15.09M | $-14083.00 | $-16836.00 | $-15976.00 | $-10.23M | $-74.30M | $-54.66M | $-142.00M | $-239.30M | $-276.00M | $-292.00M | $-113.60M | $-75.59M | $-59.99M | $-29.13M | $2000.00 | $21.59M | $30.28M | $31.11M |
| Net income growth (YoY) | — | +99.9% | -19.5% | +5.1% | -63951.6% | -626.1% | +26.4% | -159.8% | -68.5% | -15.3% | -5.8% | +61.1% | +33.5% | +20.6% | +51.5% | +100.0% | +1079450.0% | +40.2% | +2.8% |
| Profit margin | — | — | — | — | 3640.3% | — | — | — | — | — | -1054.2% | -45.3% | -27.8% | -26.7% | -11.5% | 0.0% | 9.2% | 13.1% | 13.6% |